Literature DB >> 14406801

Pharmacological characteristics of bradykinin B.

R JAQUES, R MEIER.   

Abstract

Keywords:  KALLIKREIN/pharmacology

Mesh：

Substances：

Year:  1960        PMID： 14406801     DOI： 10.1007/bf02157912

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  4 in total

1.  Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. I. An activable permeability factor and its inhibitor in guinea-pig serum.

Authors:  A A MILES; D L WILHELM
Journal:  Br J Exp Pathol       Date:  1955-02

2.  [Not Available].

Authors:  R MEIER; F GROSS; J TRIPOD; H TURRIAN
Journal:  Experientia       Date:  1957-09-15

3.  Experimental suppression of the early inflammatory phenomena of turpentine pleurisy in rats.

Authors:  W G SPECTOR; D A WILLOUGHBY
Journal:  Nature       Date:  1958-03-08       Impact factor: 49.962

4.  Liberation of histamine and formation of lysocithin-like substances by cobra venom.

Authors:  W Feldberg; C H Kellaway
Journal:  J Physiol       Date:  1938-11-14       Impact factor: 5.182
  4 in total
  3 in total

1.  [Recent results in the field of plasma kinins].

Authors:  I TRAUTSCHOLD; G RUDEL
Journal:  Klin Wochenschr       Date:  1963-04-01

2.  Biological properties of synthetic bradykinin.

Authors:  H KONZETT; R A BOISSONNAS
Journal:  Experientia       Date:  1960-10-15

Review 3.  Bradykinin, kallidin, and their synthetic analogues.

Authors:  E Schröder; R Hempel
Journal:  Experientia       Date:  1964-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.